EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Managing Azole Resistance in Aspergillus

Hisako Kushima, Hiroshi Ishii

Medical Mycology Journal · 30.04.2026 · 67 (2) · 117-123

DOI: 10.3314/mmj.26.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Mycology Journal, erschienen am 30.04.2026. Verfasst von Hisako Kushima und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Control and Prevention, Fukuoka University Chikushi Hospital. Hauptthemen laut MEDLINE: Antifungal Agents, Azoles, Drug Resistance, Fungal, Aspergillus fumigatus. Die Arbeit nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Azole antifungals are the cornerstone of therapy for aspergillosis, yet the global rise in azole-resistant Aspergillus fumigatus has become a major clinical concern. Resistance rates vary widely across regions, with particularly serious implications for chronic pulmonary aspergillosis (CPA), which requires long-term azole therapy. Resistance mechanisms largely involve cyp51A mutations, although additional genetic alterations and environmental factors, such as agricultural azole use, also play important roles. Cross-resistance among azoles is frequent, leaving clinicians with limited alternatives, such as liposomal amphotericin B or echinocandins, which are constrained by toxicity, fungistatic activity, and intravenous administration. Currently, antifungal susceptibility testing for filamentous fungi remains technically demanding and is not routinely available in many countries, including Japan, further complicating its management. Emerging approaches include the development of novel antifungal compounds and optimization of existing drugs through inhaled or nanoformulated delivery systems. Furthermore, fungal vaccines are attracting increasing attention as promising long-term solutions to stagnant antifungal pipelines and the growing challenge of drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsAzolesDrug Resistance, FungalAspergillus fumigatusHumansMicrobial Sensitivity TestsFungal ProteinsMutation

Stichwörter der Autor:innen

Aspergillus fumigatusantifungal susceptibility testingazole resistancechronic pulmonary aspergillosisnovel antifungalsvaccine development

Substanzen

Antifungal AgentsAzolesFungal Proteins

Autor:innen und Institutionen

  • Department of Infection Control and Prevention, Fukuoka University Chikushi Hospital.
  • Department of Respiratory Medicine, Fukuoka University Chikushi Hospital.

Zitieren

APA

Kushima, H., & Ishii, H. (2026). Managing Azole Resistance in Aspergillus. Medical Mycology Journal, 67(2), 117-123. https://doi.org/10.3314/mmj.26.008

Vancouver

Kushima H, Ishii H. Managing Azole Resistance in Aspergillus. Medical Mycology Journal. 2026;67(2):117-123. doi:10.3314/mmj.26.008

BibTeX
@article{Kushima2026,
  author = {Kushima, Hisako and Ishii, Hiroshi},
  title = {Managing Azole Resistance in Aspergillus},
  journal = {Medical Mycology Journal},
  year = {2026},
  volume = {67},
  number = {2},
  pages = {117--123},
  doi = {10.3314/mmj.26.008}
}
Kostenlos starten →